Bridgewater Associates LP Lowers Stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Bridgewater Associates LP decreased its position in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 12.5% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 11,962 shares of the biopharmaceutical company’s stock after selling 1,706 shares during the quarter. Bridgewater Associates LP’s holdings in Ultragenyx Pharmaceutical were worth $552,000 at the end […]
More Stories
TSS, Inc. (NASDAQ:TSSI) COO Karl Todd Marrott Sells 29,778 Shares
TSS, Inc. (NASDAQ:TSSI – Get Free Report) COO Karl Todd Marrott sold 29,778 shares of the stock in a transaction...
Insider Selling: CCC Intelligent Solutions Holdings Inc. (NYSE:CCCS) CAO Sells 9,916 Shares of Stock
CCC Intelligent Solutions Holdings Inc. (NYSE:CCCS – Get Free Report) CAO Rodney Christo sold 9,916 shares of CCC Intelligent Solutions...
Financial Comparison: Unity Biotechnology (NASDAQ:UBX) versus PainReform (NASDAQ:PRFX)
Unity Biotechnology (NASDAQ:UBX – Get Free Report) and PainReform (NASDAQ:PRFX – Get Free Report) are both small-cap medical companies, but...
Dell Technologies (NYSE:DELL) Updates FY 2025 Earnings Guidance
Dell Technologies (NYSE:DELL – Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The...
Western Asset Premier Bond Fund (NYSE:WEA) Raises Dividend to $0.07 Per Share
Western Asset Premier Bond Fund (NYSE:WEA – Get Free Report) announced a dividend on Monday, November 25th,NASDAQ Dividends reports. Shareholders...
Guess? (NYSE:GES) Issues Q4 2025 Earnings Guidance
Guess? (NYSE:GES – Get Free Report) updated its fourth quarter 2025 earnings guidance on Tuesday. The company provided earnings per...